Cryoballoon pulmonary vein ablation and left atrial appendage closure combined procedure: A long-term follow-up analysis.
Aged
Anticoagulants
/ therapeutic use
Atrial Appendage
/ diagnostic imaging
Atrial Fibrillation
/ complications
Cardiac Surgical Procedures
/ adverse effects
Cryosurgery
/ adverse effects
Echocardiography, Transesophageal
/ methods
Female
Hemorrhage
/ chemically induced
Humans
Long Term Adverse Effects
/ epidemiology
Male
Outcome and Process Assessment, Health Care
Pulmonary Veins
/ surgery
Recurrence
Septal Occluder Device
Stroke
/ epidemiology
Atrial fibrillation ablation
Combined procedure
Cryoballoon
Intracardiac echocardiography
Left atrial appendage closure
Journal
Heart rhythm
ISSN: 1556-3871
Titre abrégé: Heart Rhythm
Pays: United States
ID NLM: 101200317
Informations de publication
Date de publication:
09 2019
09 2019
Historique:
received:
31
01
2019
pubmed:
1
4
2019
medline:
18
11
2020
entrez:
1
4
2019
Statut:
ppublish
Résumé
The combined left atrial appendage closure (LAAC) and cryoenergy pulmonary vein isolation (PVI) procedure has been proven safe and effective in managing stroke in patients with nonvalvular atrial fibrillation (AF), although most data refer to procedures performed using radiofrequency as the main energy source. The purpose of this study was to evaluate long-term follow-up of patients with AF undergoing concomitant LAAC and cryoenergy PVI. Patients undergoing LAAC and cryoballoon PVI at our institution were enrolled. At 3, 6, and 24 months from the index procedure, we determined the atrial arrhythmia recurrence rate, the extent of LAAC, and the rate of cerebrovascular/bleeding events. Forty-nine patients (mean age 69 ± 8 years; 32/49 (67%) men; CHA Concomitant cryoballoon ablation and LAAC procedures appear safe and effective at long-term follow-up, with high antithrombotic drug withdrawal rates at 24 months.
Sections du résumé
BACKGROUND
The combined left atrial appendage closure (LAAC) and cryoenergy pulmonary vein isolation (PVI) procedure has been proven safe and effective in managing stroke in patients with nonvalvular atrial fibrillation (AF), although most data refer to procedures performed using radiofrequency as the main energy source.
OBJECTIVE
The purpose of this study was to evaluate long-term follow-up of patients with AF undergoing concomitant LAAC and cryoenergy PVI.
METHODS
Patients undergoing LAAC and cryoballoon PVI at our institution were enrolled. At 3, 6, and 24 months from the index procedure, we determined the atrial arrhythmia recurrence rate, the extent of LAAC, and the rate of cerebrovascular/bleeding events.
RESULTS
Forty-nine patients (mean age 69 ± 8 years; 32/49 (67%) men; CHA
CONCLUSION
Concomitant cryoballoon ablation and LAAC procedures appear safe and effective at long-term follow-up, with high antithrombotic drug withdrawal rates at 24 months.
Identifiants
pubmed: 30928784
pii: S1547-5271(19)30290-5
doi: 10.1016/j.hrthm.2019.03.022
pii:
doi:
Substances chimiques
Anticoagulants
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1320-1326Informations de copyright
Copyright © 2019 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.